Cargando…

A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice

Detalles Bibliográficos
Autores principales:	Noori, Maryam, Yadegar, Abbas, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960283/ https://www.ncbi.nlm.nih.gov/pubmed/31937640 http://dx.doi.org/10.1128/mBio.02596-19

Ejemplares similares

Reply to Noori et al., “A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice”
por: Maseda, Damian, et al.
Publicado: (2020)

Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response
por: Maseda, Damian, et al.
Publicado: (2019)

Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Surface layer protein A from hypervirulent Clostridioides difficile ribotypes induce significant changes in the gene expression of tight junctions and inflammatory response in human intestinal epithelial cells
por: Noori, Maryam, et al.
Publicado: (2022)

Nonsteroidal Anti-Inflammatory Drugs Impact on the Outcomes of Hospitalized Patients with Clostridium difficile Infection
por: Patel, Harish, et al.
Publicado: (2019)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Colonization Resistance of the Gut Microbiota against Clostridium difficile
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2015)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

71 Alterations in the Gut Microbiome in Recurrent Clostridium difficile Infection
por: Wang, Gary, et al.
Publicado: (2014)

Frequency of Clostridium difficile among patients with gastrointestinal complaints
por: Nazemalhosseini-Mojarad, Ehsan, et al.
Publicado: (2011)

Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile
por: Schubert, Alyxandria M., et al.
Publicado: (2015)

Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes
por: Skraban, Jure, et al.
Publicado: (2013)

Structural and functional changes in the gut microbiota associated to Clostridium difficile infection
por: Pérez-Cobas, Ana E., et al.
Publicado: (2014)

Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
por: Vincent, Caroline, et al.
Publicado: (2015)

Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
por: Kalakuntla, Ashish S, et al.
Publicado: (2019)

Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
por: Piccioni, Andrea, et al.
Publicado: (2022)

MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE
por: Rodríguez, C., et al.
Publicado: (2020)

2322: The effects of fecal microbiota transplantation on the gut microbiota in subjects with Clostridium difficile infection
por: Elizabeth Langdon, Amy, et al.
Publicado: (2018)

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Dietary Zinc Alters the Microbiota and Decreases Resistance to Clostridium difficile Infection
por: Zackular, Joseph P., et al.
Publicado: (2016)

Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients
por: Duan, Juping, et al.
Publicado: (2020)

Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2022)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022)

A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination
por: Shen, Aimee
Publicado: (2015)

The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity
por: Leslie, Jhansi L., et al.
Publicado: (2019)

Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection
por: Amrane, Sophie, et al.
Publicado: (2019)

Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome
por: Naseri, Kaveh, et al.
Publicado: (2021)

The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
por: Fakharian, Farzaneh, et al.
Publicado: (2022)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran
por: Goudarzi, Mehdi, et al.
Publicado: (2013)

Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients
por: Nycz, Bryan T., et al.
Publicado: (2018)

Developing Gut Microbiota Exerts Colonisation Resistance to Clostridium (syn. Clostridioides) difficile in Piglets
por: Grześkowiak, Łukasz, et al.
Publicado: (2019)

Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine
por: Theriot, Casey M., et al.
Publicado: (2016)

In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1
por: Goltsov, Alexey, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e48abtpo49211ecmu381usevlt